^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    SureSeq™ Germline Breast Cancer + CNV Panel

    Company:
    Sysmex Corp
    Type:
    Laboratory Developed Test
    Related tests:

    Details

    Evidence
    News
    The SureSeq™ Germline Breast Cancer + CNV Panel has been developed to provide comprehensive coverage of 7 key genes implicated in breast and ovarian cancer, including BRCA1 and BRCA2. Detecting SNVs and indels, as well as exon-level to whole gene CNVs, the SureSeq Germline Breast Cancer + CNV Panel provides researchers with a single NGS workflow to study clinically relevant aberrations and alleviates the burden of running multiple assays.
    Cancer:
    Breast Cancer
    Gene:
    BRCA1 (Breast cancer 1, early onset), BRCA2 (Breast cancer 2, early onset)
    Method:
    Next-Generation Sequencing (NGS)